HIV-1 long terminal repeat promoter regulated dual reporter: Potential use in screening of transcription modulators

Analytical Biochemistry

Volumn 360, Issue 2, 2007, Pages 315-317

  Ravi, Dyavar S ^a   Mitra, Debashis ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

LONG TERMINAL REPEATS;

CHEMISTRY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ENHANCED GREEN FLUORESCENT PROTEIN;

ARTICLE; DISEASE COURSE; DRUG SCREENING; FLUORESCENCE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33845724646     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.10.020     Document Type: Article

References (18)

1. Gould S.J., and Subramani S. Firefly Luciferase as a tool in molecular and cell biology. Anal. Biochem. 175 (1988) 5-13
2. Chalfie M., Tu Y., Euskirchen G., Ward W.W., and Prasher D.C. Green fluorescent protein as a marker for gene expression. Science 263 (1994) 802-805
3. Yu Y.A., Szalay A.A., Wang G., and Oberg K. Visualization of molecular and cellular events with green fluorescent proteins in developing embryos: a review. Luminescence 18 (2003) 1-18
4. Pereira L.A., Bentley K., Peeters A., Churchill M.J., and Deacon N.J. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 28 (2000) 663-668
5. Brigati C., Giacca M., Noonan D.M., and Albini A. HIV Tat, its TARgets, and the control of viral gene expression. FEMS Microbiol. Lett. 220 (2003) 57-65
6. Daelemans D., De Clercq E., and Vandamme A.M. A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors. J. Virol. Methods 96 (2001) 183-188
7. Ramirez D.A., Soriano V., and Holguin A. Regulation of transcription in different HIV-1 subtypes. Enferm. Infec. Microbiol. Clin. 23 (2005) 156-162
8. Gervaix A., West D., Leoni L.M., Richman D.D., Wong-Staal F., and Corbeil J. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc. Natl. Acad. Sci. USA 94 (1997) 4653-4658
9. Miyake H., Iizawa Y., and Baba M. Novel reporter T-cell line highly susceptible to both CCR5- and CXCR4-using human immunodeficiency virus type 1 and its application to drug susceptibility tests. J. Clin. Microbiol. 41 (2003) 2515-2521
10. Princen K., Hatse S., Vermeire K., De Clercq E., and Schols D. Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists. Retrovirology 1 (2004) 1-13
11. Felber B.K., and Pavlakis G.N. A quantitative bioassay for HIV-1 based on trans-activation. Science 239 (1988) 184-187
12. Koseki S., Ohkawa J., Yamamoto R., Takebe Y., and Taira K. A simple assay system for examination of the inhibitory potential in vivo of decoy RNAs, ribozymes, and other drugs by measuring the Tat-mediated transcription of a fusion gene composed of the long terminal repeat of HIV-1 and a gene for Luciferase. J. Control Release 53 (1988) 159-173
13. Kimpton J., and Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66 (1992) 2232-2239
14. Spira S., Wainberg M.A., Loemba H., Turner D., and Brenner B.G. Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity, and drug resistance. J. Antimicrob. Chemoth. 51 (2003) 229-240
15. Mochizuki N., Otsuka N., Matsuo K., Shiino T., Kojima A., Kurata T., Sakai K., Yamamoto N., Isomura S., Dhole T.N., Takebe Y., Matsuda M., and Tatsumi M. An infectious DNA clone of HIV type 1 subtype C. AIDS Res. Hum. Retroviruses 15 (1999) 1321-1324
16. Ranga U., Shankarappa R., Siddappa N.B., Ramakrishna L., Nagendran R., Mahalingam M., Mahadevan A., Jayasuryan N., Satishchandra P., Shankar S.K., and Prasad V.R. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J. Virol. 78 (2004) 2586-2590
17. West M.J., and Karn J. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer. EMBO J. 18 (1999) 1378-1386
18. Van Lint C. Role of chromatin in HIV-1 transcriptional regulation. Adv. Pharmacol. 48 (2000) 121-160